Corvus Pharmaceuticals Competitors and Similar CompaniesClear all
Corvus Pharmaceuticals's competitors and similar companies include DAVA Oncology, Actuate Therapeutics, PLx Pharma and Progenics Pharmaceuticals.
 Corvus Pharmaceuticals Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. |  DAVA Oncology DAVA Oncology is a company that provides solutions and services to the pharmaceutical and biotechnology industries aiming to support cancer drug development. |  Actuate Therapeutics Actuate Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic agents for patients with cancer or inflammatory diseases. |  PLx Pharma PLx Pharma is a specialty pharmaceutical company focused on its clinically-validated PLxGuard drug delivery platform. |  Progenics Pharmaceuticals Progenics Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapeutics for cancer patients. | |
Founding Date | Founding Date 2014 | Founding Date 2007 | Founding Date 2015 | Founding Date 2002 | Founding Date 1986 |
Type | Type Public | Type Private | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Burlingame, US HQ | Locations Dallas, US HQ | Locations Fort Worth, US HQ Dublin, IE | Locations Sparta, US HQ Houston, US Woodmere, US | Locations New York, US HQ Billerica, US |
Employees | Employees 4911% decrease | Employees 823% increase | Employees 1067% increase | Employees 16100% increase | Employees 49 |
Valuation ($) | Valuation ($) 556.1 m | Valuation ($) N/A | Valuation ($) 180.3 m | Valuation ($) 2.5 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $8.2m (FY, 2021) | Revenue (est.) $35m (FY, 2019) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $4.8m (FY, 2021) | Cost of goods $3.2m (FY, 2019) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit $3.4m (FY, 2021) | Gross profit $31.8m (FY, 2019) |
Net income | Net income ($15.3m) (FY, 2025) | Net income N/A | Net income ($22.2m) (FY, 2025) | Net income ($46.1m) (FY, 2021) | Net income ($68.6m) (FY, 2019) |
For sources of this data, please see the company profile
View Company Profiles
DAVA Oncology
HQ
Dallas, US
Employees
82↑ 3% increase
DAVA Oncology is a company that provides solutions and services to the pharmaceutical and biotechnology industries aiming to support cancer drug development.
View companyActuate Therapeutics
HQ
Fort Worth, US
Employees
10
Actuate Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic agents for patients with cancer or inflammatory diseases.
View companyPLx Pharma
HQ
Sparta, US
Employees
16
PLx Pharma is a specialty pharmaceutical company focused on its clinically-validated PLxGuard drug delivery platform.
View companyProgenics Pharmaceuticals
HQ
New York, US
Progenics Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapeutics for cancer patients.
View company